From the publishers of JADPRO
CAR T-Cell Therapy
Resource Center
Menu
Resources
Videos
Videos
Fast Facts
Quizzes
News & Literature Highlights
Case Studies
Advertisement
Test your knowledge of atypical manifestation of neurotoxicity following CAR T-cell therapy
Last Updated: Friday, October 11, 2024
Advertisement
News & Literature Highlights
Nature Medicine
Long-term outcomes of GD2-directed CAR-T cell therapy in patients with neuroblastoma
Blood Advances
Access barriers to anti-CD19+ CART therapy for NHL across a community transplant and cellular therapy network
Blood
Development of ALL-Hematotox (ALL-HT): Predicting post CAR T-cell hematotoxicity in B-cell acute lymphoblastic leukemia
Science Advances
Development of an antigen-based approach to noninvasively image CAR T cells in real time and as a predictive too
JAMA Network Open
Cardiovascular events after chimeric antigen receptor T-cell therapy for advanced hematologic malignant neoplasms: A meta-analysis
Blood Advances
Outcome of patients with large B-cell lymphoma treated with tafasitamab plus lenalidomide either before or after CAR T-cell therapy
Blood Advances
Access barriers to anti-CD19+ CAR T-cell therapy for NHL across a community transplant and cellular therapy network
Blood Advances
EASIX and m-EASIX predict CRS and ICANS in pediatric and AYA patients post CD19-CAR T cell therapy
Blood Advances
Local radiation enhances systemic CAR T cell efficacy by augmenting antigen cross-presentation and T-cell infiltration
Blood Advances
Feasibility and favorable responses following investigational CAR T-Cell therapy for relapsed and refractory infant ALL
Advertisement
Case Studies
Transverse Myelitis With Paraplegia: An Atypical Manifestation of Neurotoxicity Following CAR T-Cell Therapy
CAR T-cell Infusion in an Outpatient Setting: An Ideal Option for Selected Patients When Available
B-Cell Aplasia, Hypogammaglobulinemia Can Result in Serious, Life-Threatening Infections
Fast Facts
Fast Facts #12: BCMA Targets
Advertisement
Quizzes
Test your knowledge of atypical manifestation of neurotoxicity following CAR T-cell therapy
Test your knowledge of CAR T-cell therapy
Test your knowledge of CAR T-cell infusion in an outpatient setting